POT1 and cutaneous squamous cell carcinoma: Deleterious POT1 mutations are present in approximately 3% of all tumors, with a higher prevalence in angiosarcomas, non-small-cell lung cancers, and cutaneous squamous cell carcinomas and melanomas.